News

Vetanco & Bioinnovo at the CRWAD Conference

Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually last December 5-8. The “Conference of Research Workers in Animal Diseases 2020”, locally known as “CRWAD 2020 Conference” took place last December 5-8 in a virtual modality.   Bioinnovo–Vetanco and Vetanco USA specialists…

A new achievement in the fight against COVID-19

A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 virus. The project “Development and production of critical reagents for diagnosis and treatment of COVID-19: Nanoantibodies, IgY polyclonal antibodies, and recombinant proteins” gathers researchers of INTA, CONICET, the National Institute of Infectious Diseases…

100% Argentinian technology for the COVID-19 test

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an essential device for a rapid diagnostic test to substitute imports, reduce costs to the half and meet the local demand that is currently with a shortage of stock. This device…

Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis

Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are the Institute of Science and Technology César Milstein (Conicet –…

Bioinnovo, Algenex reinforce vaccine molecule Arrangement

Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting cells homing) molecule in the _eld of animal health. Bioinnovo…